Elsevier Inc.

SHERPA: Unknown

People

  1. Yahalom
    Yahalom
  2. Devlin
    Devlin
  3. Scordo
    Scordo
  4. Shah
    Shah
  5. Dahi
    Dahi
  6. Giralt
    Giralt
  7. Hajj
    Hajj
  8. Hamlin
    Hamlin
  9. Imber
    Imber
  10. Moskowitz
    Moskowitz

Groups

  1. Biostatistics Service (6)
  2. Center for Hematologic Malignancies (6)
  3. Department of Medicine (6)
  4. Epidemiology and Biostatistics (6)
  5. Hematologic Malignancies, Division of (6)
  6. Lymphoma (6)
  7. Radiation Oncology, Department of (6)
  8. Survivorship Research (6)
  9. Bone Marrow Transplant (4)
  10. CTCR Scholars (3)
Search Within
  1. "Lymphoma"
  2. "Joachim Yahalom"
  3. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (3)
Groups
  1. Biostatistics Service (6)
  2. Center for Hematologic Malignancies (6)
  3. Department of Medicine (6)
  4. Epidemiology and Biostatistics (6)
  5. Hematologic Malignancies, Division of (6)
  6. Lymphoma (6)

More Groups

People
  1. Joachim Yahalom (6)
  2. Craig Moskowitz (4)
  3. Craig Sauter (3)
  4. Gunjan Shah (3)
  5. Matthew Matasar (3)
  6. Michael Scordo (3)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2018 (1)
  4. 2017 (2)
  5. 2008 (1)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (3)
  2. Biology of Blood and Marrow Transplantation (2)
  3. Transplantation and Cellular Therapy (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Patterns of relapse and risk reduction following tumor debulking by bridging radiotherapy prior to chimeric antigen receptor T cell therapy in non-Hodgkin lymphoma
    Meeting Abstract

    Hubbeling, H. G.; Silverman, E. A.; Michaud, L.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Alarcon Tomas, A.; Shouval, R.; Palomba, M. L.; Batlevi, C. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Outcomes of relapsed and refractory primary mediastinal (thymic) large B cell lymphoma treated with second-line therapy and intent to transplant
    Journal Article

    Vardhana, S.; Hamlin, P. A.; Yang, J.; Zelenetz, A.; Sauter, C. S.; Matasar, M. J.; Ni, A.; Yahalom, J.; Moskowitz, C. H.
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Early toxicities associated with radiation based conditioning for relapsed/refractory Hodgkin lymphoma patients undergoing high dose therapy and autologous stem cell transplantation (HDT-ASCT)
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Devlin, S. M.; Yahalom, J.; Matasar, M. J.; Moskowitz, A.; Giralt, S. A.; Moskowitz, C. H.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Accelerated total lymphoid irradiation-containing salvage regimen for patients with refractory and relapsed Hodgkin lymphoma: 20 years of experience
    Journal Article

    Rimner, A.; Lovie, S.; Hsu, M.; Chelius, M.; Zhang, Z.; Chau, K.; Moskowitz, A. J.; Matasar, M.; Moskowitz, C. H.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Influence of post-second-line chemotherapy PET Imaging and involved field radiotherapy prior to high dose therapy on outcomes of relapsed or refractory diffuse large B cell lymphoma
    Meeting Abstract

    Hoppe, B. S.; Moskowitz, C. H.; Zhang, Z.; Kewalramani, T.; Maragulia, J. C.; Rice, R. D.; Reiner, A. S.; Hamlin, P. A.; Zelenetz, A. D.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2008)

    Fulltext@MSK | Save